Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Total Current Liabilities: 2020-2025

Historic Total Current Liabilities for Biofrontera (BFRI) over the last 4 years, with Sep 2025 value amounting to $12.6 million.

  • Biofrontera's Total Current Liabilities rose 13.79% to $12.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.6 million, marking a year-over-year increase of 13.79%. This contributed to the annual value of $12.0 million for FY2024, which is 33.54% down from last year.
  • According to the latest figures from Q3 2025, Biofrontera's Total Current Liabilities is $12.6 million, which was down 36.24% from $19.7 million recorded in Q2 2025.
  • Biofrontera's 5-year Total Current Liabilities high stood at $29.1 million for Q3 2023, and its period low was $9.3 million during Q2 2024.
  • For the 3-year period, Biofrontera's Total Current Liabilities averaged around $15.7 million, with its median value being $13.3 million (2024).
  • As far as peak fluctuations go, Biofrontera's Total Current Liabilities soared by 213.03% in 2021, and later slumped by 62.12% in 2024.
  • Quarterly analysis of 5 years shows Biofrontera's Total Current Liabilities stood at $13.8 million in 2021, then spiked by 51.01% to $20.9 million in 2022, then decreased by 13.43% to $18.1 million in 2023, then slumped by 33.54% to $12.0 million in 2024, then increased by 13.79% to $12.6 million in 2025.
  • Its last three reported values are $12.6 million in Q3 2025, $19.7 million for Q2 2025, and $11.0 million during Q1 2025.